Contract facts
NONENo full NAICS 334510 intel page yet. Browse NAICS intelligence
ITEMIZED MEDICAL SUPPLIES FOR THE TREATMENT OF PATIENTS BEING TREATED AT THE CARDIOVASCULAR HEALTH AND INTERVENTIONAL RADIOLOGY DEPARTMENT AT WALTER REED is a federal NONE award for Defense Health Agency held by Biosense Webster, Inc. Estimated value $400K ($400K obligated). Current period of performance ends Jan 31, 2024. Last award drew 1 bidder. Place of performance: BETHESDA MD.
ITEMIZED MEDICAL SUPPLIES FOR THE TREATMENT OF PATIENTS BEING TREATED AT THE CARDIOVASCULAR HEALTH AND INTERVENTIONAL RADIOLOGY DEPARTMENT AT WALTER REED
Recompete timing
PublicCurrent PoP ended Jan 31, 2024 (933 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordBiosense Webster, Inc — $41.9M obligated across 136 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract HT001424F0017?
HT001424F0017 (Itemized medical supplies for the treatment) is a Defense Health Agency award with a potential value of $400K, currently held by Biosense Webster, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is HT0014-24-F-0017?
HT0014-24-F-0017 is the dashed form of PIID HT001424F0017 (Itemized medical supplies for the treatment), held by Biosense Webster, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded HT001424F0017?
Defense Health Agency awarded HT001424F0017 to Biosense Webster, Inc (potential $400K).
Who is the incumbent on HT001424F0017?
Biosense Webster, Inc is the incumbent with $41.9M across 136 related awards in SCOUT’s public footprint. The current period of performance ends Jan 31, 2024.
When does Biosense Webster, Inc’s HT001424F0017 come up for recompete?
SCOUT tracks a period-of-performance end of Jan 31, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.